Credits
Hosts/Writing: Sara Dong & Jonathan Ryder
Producing/Editing/Cover Art: Sara Dong
Our Guest
Jonathan Ryder, MD
Jonathan Ryder, MD is an infectious diseases fellow at University of Nebraska Medical Center in Omaha, NE. He completed his internal medicine residency at Indiana University. His academic interests include medical education, endocarditis, and antimicrobial stewardship. He enjoys podcasts and #IDTwitter. His hobbies include running, reading non-fiction, and NFL football.
Culture
Jonathan: Walking Dead series and the Fear of the Walking Dead
Sara: Squid Game and Star Wars Visions
Consult Notes
We would like to thank the presenters, moderators, and organizers of IDWeek2021!! Please see IDWeek website for more information! For those viewing sessions on demand, I’ve tried to include the speakers and session numbers so that you are able to find them.
We started by mentioning the Fellows Day workshops at IDWeek, which are great opportunities to hear a few interesting cases, meet new ID colleagues, and hear some career development/fellow-targeted talks from the organizers. Highlighted a few pearls from the cases we enjoyed:
- Pediatric Fellows Day:
- A case of Legionella feeleii in a neonate, source was ultimately attributed to a humidifier
- Very uncommon pathogen for a neonate, but high mortality. Good reminder of the differential diagnosis of etiologies that can cause fulminant sepsis in an otherwise normal neonate (such as enterovirus, parechovirus, adenovirus, HSV, GBS, enteric GNR)
- Consider Legionella as pathogen if see GNRs on gram stain that aren’t growing in routine respiratory cultures
- Remember special media is required for culture of Legionella → typically buffered charcoal yeast extract (BCYE) agar, which is supplemented with alpha-ketoglutarate and rich with iron and L-cysteine
- Thank you to PIDS moderators, organizers, and panelists (Buddy Creech, Tanvi Sharma)!
- A case of Legionella feeleii in a neonate, source was ultimately attributed to a humidifier
- Adult Fellows Day:
- Severe HSV hepatitis in pregnancy → lack of herpetic lesions does NOT rule out HSV and can lead to a delay in diagnosis ! Don’t forget about hepatitis E as a cause of fulminant disease in pregnancy as well
- Disseminated cryptococcosis in young male patient with HIV/AIDS → uncommon presentation of disease with diffuse lymphadenopathy, pericardial effusion, cavitary lung lesion, atypical rash, without convincing evidence of CNS disease
- Don’t forget to check out ID Images for more cases, and the IDWeek cases get uploaded to this site eventually! Thank you to moderators Rajesh Gandhi and Lisa Chirch as well as panelists (Natasha Chida, Stuart Cohen, Sarah Turbett)
Dr. Patricia Whitley-Williams was invited for the Edward Kass lecture, but due to technical difficulties, her time was cut short. We hope to hear her discuss the epidemic of structural racism within the COVID pandemic in the future!
A few notes from some of the interesting “Challenging Case” sessions!
Diagnostic Clinical Cases (Session 05 — Moderators James Dunn, Esther Babady; Panelists Francesca Lee, Christopher Doern, Colleen Kraft, Samuel Dominguez)
- It’s not just MTB — other mycobacterial spp can lead to cording!
- Meliodosis case was a nice reminder about the recent non-travel related cases
Pediatric ID cases (Session 31 — Moderators Isaac Thomsen, Sharon Chen; Panelists Surabhi (Sara) Vora, Victoria Statler, Upton Allen, Roberta DeBiasi)
- Leptospirosis can lead to non-oliguric renal injury
- Another interesting case was related to Bartonella endocarditis that was diagnosed after a 2 year presentation mimicking ALPS (inherited autoimmune lymphoproliferative syndrome)
Transplant / Immunocompromised Host cases (Session 131 — Moderators Pearlie Chong, Steven Pergam; Panelists Fernanda Silveira, Jennifer Saullo, Upton Allen)
- Rothia mucilaginosa: often thought of with bacteremia in neutropenic pts with severe mucositis, but can also be associated with sepsis, pneumonia, and severe meningitis in rare cases! Delayed meningitis symptoms can occur, particularly among neutropenic pts and those on high dose steroids, which may lead to delay in diagnosis as well
- Most M.abscessus subspecies have an active erm gene, but M.abscessus subspp massiliense typically does not.
Tropical medicine cases (Session 18 — Moderators Laila Woc-Colburn, Heather Yun; Panelists Patrick Hickey, Andrea Boggild, Edsel Maurice Salvana, Paola Lichtenberger)
- Chromoblastomycosis, which is chronic fungal infection of skin or subcutaneous tissue with dematiaceous fungi → organisms present in soil and due to direct subcutaneous inoculation or spore inhalation → characterized histologically by sclerotic bodies ( copper pennies )
- CARD9 genetic deficiency associated with severe dz
- Also featured cases of Babesia and leptospirosis — loved the shout-out to rely on your network and community to ask about cases. Ok to be humble and look it up
- Chromoblastomycosis, which is chronic fungal infection of skin or subcutaneous tissue with dematiaceous fungi → organisms present in soil and due to direct subcutaneous inoculation or spore inhalation → characterized histologically by sclerotic bodies ( copper pennies )
HIV Diagnosis cases (Multiple Challenging HIV case sessions, including 32, 50)
- Importance of follow-up with ophthalmology for CMV retinitis and to be aware of CMV immune recovery uveitis which could present later
- Importance of recognizing ART regimens that are recommended in pregnancy
- Safe to use DTG in pregnancy despite prior concerns with neural tube defects, current guidelines recommend keeping on same ART if safe & effective during pregnancy (be wary of cobicistat)
- Great advice regarding breastfeeding recommendations, contrasting guidelines between CDC & WHO for HIV
- Importance of assessing patient’s motivations, understanding of risks of transmission, emphasize working as a team for the child & negotiating risk mitigation
Several of these learning points are also covered in prior Febrile episodes!
We covered several topics in the next section, mostly related to endovascular infections.
We covered several topics in the next section, mostly related to endovascular infections.
Clinical Controversies in Staph aureus bacteremia (Session 53)
- Rizwan Sohail – Updates in SAB Diagnosis and Prognosis
- Discussion of the so-called “skip phenomenon” in SAB: BCx intermittently positive on serial testing (Up to 4% in one study with skip phenomenon) → Be wary of a single negative BCx in SAB
- Consider serial negative BCx in high risk groups: males >65 years old, chronic immunosuppression & prolonged bacteremia
- Also look for a VIRSTA vs PREDICT vs POSITIVE scoring systems for decision tools on when to check echocardiograms, especially TEE, then look for discussion of PET CT in SAB
- Discussion of the so-called “skip phenomenon” in SAB: BCx intermittently positive on serial testing (Up to 4% in one study with skip phenomenon) → Be wary of a single negative BCx in SAB
- Todd Lee – Treatment Approach for S.aureus Bacteremia
- Importance of randomized vs random care: true need for well-controlled trials to determine areas of controversy, even if more difficult, compared to observational studies with confounding & biases
- Top trials Jonathan pointed out that he is looking forward to:
- DOTS trial: vanc/dapto vs dalbavancin for SAB
- SNAP trial: pragmatic trial looking at multiple questions with a Bayesian framework
- Vanc +/- cefazolin, penicillin vs flucloxacillin for PSSA, cefazolin vs flucloxacillin, oral stepdown
- CERT trial: cefazolin + ertapenem vs cefazolin for MSSA
- RODEO: PO levo + rif as stepdown for SA IE, similar to POET
- DISRUPT: standard of care +/- exebacase (lysin, not an antibiotic) for MRSA
- SAB7: 7 vs 14 days for uncomplicated SAB
- See full lecture for details of clinical trial design, expected result timeline, etc
- Rizwan Sohail – Updates in SAB Diagnosis and Prognosis
Hot Issues in E. Faecalis Bacteremia/Endocarditis (Session 12)
- Juan Pericas – Association of E.faecalis bacteremia/endocarditis and colonic neoplasms
- Relationship between E. faecalis & colon cancer is not entirely clear, whether it is important in driving cancer formation or may simply take advantage of lesions → Appears to be a relationship between EF IE & colonic lesions
- Reasonable to recommend colonoscopy in those >50 years of age or other risk factors for CRC in community-acquired EF IE or unknown source of BSI, on-going studies, especially in BSI
- Anders Dahl – Should positive blood cultures with E.faecalis be upgraded to count as major criteria for endocarditis?
- Makes convincing argument that IE guidelines & Duke criteria need updated, currently only consider community-acquired E. faecalis without a clear foci as a “typical IE bug,” but rather, all cases (including HA & known source) of E. faecalis should be evaluated for IE, as community-acquired & absence of foci are not sensitive for identifying all cases of EF IE
- Shows that E. faecalis has similar rates of endocarditis as SAB (~25%), with only ~40% community onset, ~50% with unknown focus–>E. Faecalis is a “typical IE bug”
- Juan Pericas – Association of E.faecalis bacteremia/endocarditis and colonic neoplasms
Updates in Natural & Prosthetic Vascular Graft Infections (Session 101; Speakers Daniel DeSimone, Barbara Hasse, Andres Perissinotti)
- VGIs are common, but difficult & somewhat underappreciated, often requires a lot of communication with the surgeon
- Important to stratify type of infection into Samson criteria, which define the extent of the infection, regarding depth & involvement of the graft, this stratifies into medical vs surgical management
- Newer criteria to diagnose an infection: MAGIC criteria, uses compilation of clinical, surgical, radiologic & laboratory findings
- This lecture taught me the importance of understanding our surgical colleagues perspective and the importance of a multidisciplinary team. Also made me aware of US & European guidance on this topic
- Reasons for possible lifelong suppression: MRSA, Pseudomonas, MDR organism, fungi (e.g., Candida), numerous surgeries for infections, an emergency surgery with rifampin-bonded graft for reconstruction, extensive surrounding infection & poor candidate for reoperation
- Lot of discussion regarding PET/CT utility in these infections: higher sensitivity/specificity compared to CT angiography,, detection of metastatic sites of infection, differentiate between infection & sterile inflammatory areas due to surgery, etc., expert discussion in the use of serial PET/CT as a modality to decide if it is safe to discontinue suppressive therapy (in compilation with clinical & laboratory markers of inflammation)
Here are the links to the two selections we discussed from the Top 10 papers in medical mycology (Session 120) — Clinical focus with Thomas Patterson
- Maertens JA, Rahav G, Lee DG, et al. Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial [published correction appears in Lancet. 2021 Aug 7;398(10299):490]. Lancet. 2021;397(10273):499-509. doi:10.1016/S0140-6736(21)00219-1 (also mentioned this in the Controversies and challenges in pediatric TID session)
- Breazzano MP, Bond JB 3rd, Bearelly S, et al. American Academy of Ophthalmology Recommendations on Screening for Endogenous Candida Endophthalmitis [published online ahead of print, 2021 Jul 19]. Ophthalmology. 2021;S0161-6420(21)00526-1. doi:10.1016/j.ophtha.2021.07.015
- The American Academy of Ophthlamology recommendations on screening for endogenous candida endophthlamitis — they suggested against routine consultation for candidemia
- Argued that low-value practice associated with cost and risk
- Which you all know is in contrast to the IDSA candidiasis guidelines
- Here are a few related papers as well if you want to dig into the debate and data:
- Oude Lashof AM, Rothova A, Sobel JD, et al. Ocular manifestations of candidemia. Clin Infect Dis. 2011;53(3):262-268. doi:10.1093/cid/cir355
- Breazzano MP, Day HR Jr, Bloch KC, et al. Utility of Ophthalmologic Screening for Patients With Candida Bloodstream Infections: A Systematic Review. JAMA Ophthalmol. 2019;137(6):698-710. doi:10.1001/jamaophthalmol.2019.0733
- Uppuluri A, Zarbin MA, Budoff G, Bhagat N. Risk Factors for Endogenous Endophthalmitis in Hospitalized Patients with Candida Fungemia. Ophthalmol Retina. 2021;5(7):687-695. doi:10.1016/j.oret.2020.10.007
- Vinikoor MJ, Zoghby J, Cohen KL, Tucker JD. Do all candidemic patients need an ophthalmic examination?. Int J Infect Dis. 2013;17(3):e146-e148. doi:10.1016/j.ijid.2012.12.014
- Jonathan alsomentioned his poster: Is There Value of Infectious Diseases Consultation in Candidemia? A Single Center Retrospective Review from 2016-2019 #IDWeek2021 https://cdmcd.co/Rr6GzJ
- The American Academy of Ophthlamology recommendations on screening for endogenous candida endophthlamitis — they suggested against routine consultation for candidemia
Some links and notes from the topics Sara covered related to pediatric ID and transplant ID.
Controversies and challenges in pediatric TID (Session 97)
- Beth Knackstedt – Empiric and prophylactic antifungal therapy in pediatric solid organ transplant patients
- Exciting from peds perspective is that there is a new formulation of posaconazole on its way early next yr (2022): Noxafil Powdermix
- Groll AH, Abdel-Azim H, Lehrnbecher T, et al. Pharmacokinetics and safety of posaconazole intravenous solution and powder for oral suspension in children with neutropenia: an open-label, sequential dose-escalation trial. Int J Antimicrob Agents. 2020;56(3):106084. doi:10.1016/j.ijantimicag.2020.106084
- Just a few references for the newer antifungals:
- Rauseo AM, Coler-Reilly A, Larson L, Spec A. Hope on the Horizon: Novel Fungal Treatments in Development. Open Forum Infect Dis. 2020;7(2):ofaa016. Published 2020 Jan 12. doi:10.1093/ofid/ofaa016
- Hoenigl M, Sprute R, Egger M, et al. The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin [published online ahead of print, 2021 Oct 9]. Drugs. 2021;10.1007/s40265-021-01611-0. doi:10.1007/s40265-021-01611-0
- I also mentioned on the show about the PIDS virtual case conference of the immunocompromised child which you can check out on the PIDS website here
- Beth Knackstedt – Empiric and prophylactic antifungal therapy in pediatric solid organ transplant patients
Mano-a-mano debate (Session 103; Moderators Hayley Gans, Gabriella Lamb). The three topics this year (and speakers) included:
- Clinical utility of next generation sequencing – William Muller; Nanda Ramchandar
- SA line infections – to remove or retain lines – Isaac Thomsen, James Wood
- Duration of treatment for BSI in neutropenic patients (fixed duration vs dependent on count recovery) — Surabhi (Sara) Vora, Rebecca Same
ID complications associated with novel cellular and immunotherapies in cancer (Session 123; Moderators Jay Fishman, Pearlie Chong; Speakers Mark Lustberg, Joshua Hill, Nirali Shah)
- Excellent overview of CAR-T (chimeric Ag receptor T) cell therapy, which uses genetically modified t-cells to fight cancer, as well as BiTEs (bi-specific T-cell engagers), such as blinatumomab
- Some take-homes would be:
- Understanding complications such as cytokine release syndrome and CAR-T toxicities can have overlapping presentations with infections
- Emphasizing net state of IS –> CAR-T cell recipients have high net state of immunosuppression that includes
- their extensive past treatment,
- lymphodepleting chemotherapy prior to infusion,
- CRS and neurotoxicity,
- depletion of both malignant and normal/healthy B cell subsets – concept of ‘on target’ (effect cancer cells) but also ‘off target’ ‘off tumor’ effects (b-cell aplasia), which can introduce ID risks
- Prophylaxis with antibiotics and immunoglobulins is varaible and not standardized. You can check out this How I Treat article from Joshua Hill for some guidance though: Hill JA, Seo SK. How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies. Blood. 2020;136(8):925-935. doi:10.1182/blood.2019004000
Top practice changing papers in transplant ID (Session 79; Moderators Pearlie Chong & Steven Pergam)
- Featured 5 papers from SOT (Judith Anesi) + 5 papers from HSCT (Maheen Abidi)
- Check out the full collection here
- The ones mentioned on the podcast:
- Taccone FS, Bogossian EG, Tironi RM, et al. Early β-lactam concentrations and infectious complications after lung transplantation. Am J Transplant. 2021;21(7):2489-2497. doi:10.1111/ajt.16432
- Elgarten CW, Li Y, Getz KD, et al. Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host Disease. Transplant Cell Ther. 2021;27(2):177.e1-177.e8. doi:10.1016/j.jtct.2020.10.012
Our last miscellaneous section!
Big & Little Beasts & the Infectious Diseases They Cause (Session 107; Moderators Belinda Ostrowsky, Teresa Zembower)
- Andrew Janowski – All Bark & Some Bite–Animal Bites
- Dogs are the most common source of bite injury in the US: 4.5 of 5 million bites per year! Predominantly in younger children, more often in boys, frequently in head/neck area in younger children but then moves to arms/legs in older children, usually by a family dog or known dog. Even seen an increase in dog bites during the pandemic
- Cat bites have the highest risk of infection though, ~50%
- Most bite infections polymicrobial, average of 7 organisms per bite, Pasteurella, Staph & Strep (skin & mouth flora) most common in cats/dogs, humans with Staph & Strep, also Eikenella, anaerobes prevalent as well
- Treatment: amox-clav, alternative TMP-SMX + metronidazole
- Obviously worry about rabies if rabid, but also tetanus from dogs/cats. Human bites with case reports of HIV, hepatitis & syphilis transmission (but overall low risk, but have to risk assess for PPx)
- Lastly, he provides a great link to a Clinical Microbiology Reviews article on the microbiology of various animal bite wound infections, including bears, sharks, Tasmanian devils, alligators, and komodo dragons….in case you ever need that information
- Stephen Cole, a veterinary microbiologist — MDR organisms in companion animals
- 2 Staph species associated with dogs/cats:
- Staphylococcus pseudintermedius, a coagulase positive Staph species with numerous virulence factors including urease, predisposing it to cause urinary stones in dogs, similar to Staph saprophyticus, frequently misidentified as Staph aureus, although improved in MALDI-TOF era, additionally, it carries MecA and often has limited antibiotic options
- Staph schleiferi is another, causes otitis externa in dogs
- Both pathogens reported in humans, usually methicillin resistant
- MRSA uncommon in cats/dogs, but more common in horses, has been reportedly transmitted between people & animals
- CRE in companion animals: rare, but reported, possible transmission amongst humans & pets
- 2 Staph species associated with dogs/cats:
- Camille Cotton — Animal-related infections in ICH
- Importance of pre- & post-transplant education to our patients on risk of infections from animals, proper risk mitigation & avoidance techniques, also importance of exposure history when presenting with infectious symptoms but also pre-transplant to mitigate risks
- Presented a case of cryptococcosis related to birds nesting in a house
- Infections associated with birds: avian flu, campylobacter, salmonella, E. coli, Histo, Crypto & Psittacosis
Clinical Pearls in Outpatient ID: Field Notes from the Frontlines (Session 118; Moderator Adarsh Bhimraj; Speakers Ole Vielemeyer, Kristin Englund)
- Common outpatient situations: positive HSV or EBV serologies, chronic pain syndromes, +syphilis serology in setting of dementia, delusional parasitosis
- Pearls: important to empathize with patient, listen to them, prepare well in advance to know these cases & testing well, difficult with medically unexplained or poorly defined diagnoses, need to set limits
Controversies in Antimicrobial Stewardship (Session 35; Moderators Daniel Morgan, Jacqueline Bork)
- Erin McCreary: Importance of diagnostic stewardship
- Right test, right time, right patient, right action
- Options to intervene during the ordering/collection phase (order sets, restrictions on tests such as UCx or CDiff indications, etc), processing phase (e.g., multistep algorithms…CDiff GDH antigen–>toxin–>PCR or HIV Ab–>confirmatory test), reporting phase (comments for interpretation the so-called “nudge,”, suppressing extraneous results e.g., susceptibilities)
- Meghan Jeffres: how best to utilize time for ASP, is de-escalation of spectrum worth the effort?
- Presents a nuanced argument using available data, showing that no definitive evidence demonstrates de-escalation of antibiotic spectrum improves patient outcomes or prevents the development of resistance. This is SO controversial (hence the session name), but in a lot of ways, ANY antibiotic therapy increases risks of CDiff, resistance, etc in the studies, plus many limitations of the evidence. Ultimately, we need better quality evidence on the subject, but her argument is perhaps ASP should spend their limited times on more evidence based interventions (IV to PO conversions, decrease total duration of antibiotics, etc)
- Alison Tribble: great overview of handshake stewardship, evidence overview, compared to prospective audit/feedback & preauthorization, in-person vs remote, because handshake is time-intensive, perhaps implementing in select units or teams
Medical Education Sessions:
- Developing and maintaining expertise: deliberate practice for ID learners of all ages (Session 23)
- Moderators Michael Angarone, Ryan Maves
- Speakers Diane Wayne, Emily Abdoler, Dana Blyth
- Language Matters: Integrating inclusive language in ID education and patient care (Session 06)
- Moderators Brian Schwartz, Jennifer Cuellar-Rodriguez
- Speakers Mary Catherine Beach, Orlando Harris
- Strategies for optimizing ID case conference: an educator’s toolkit (Session 33)
- Moderators Christopher Ohl, Vera Luther
- Speakers Varun Phadke, Jennifer Spicer
- Re-envisioning your ID curricula through a non-oppressive/anti-racist lens (Session 57)
- Moderator Christopher Ohl
- Speakers Alexandre White, Erica Johnson, Yvonne Maldonado
Episode Art & Infographics
No specific new infographics for this IDWeek episode
Goal
Listeners will be able to learn about a few sessions from IDWeek 2021 conference
Learning Objectives
After listening to this episode, listeners will be able to:
- Identify a few available sessions at IDWeek 2021
Disclosures
Febrile podcast and hosts report no relevant financial disclosures
Citation
Ryder, J., Dong, S. “#23: Febrile Faves from IDWeek 2021”. Febrile: A Cultured Podcast. https://player.captivate.fm/episode/47f97903-eb7e-4698-bfd8-a79360efca33